HCPCS Code J3372

Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg
Code effective Jul 01, 2025

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J3372 is a valid 2026 HCPCS code meaning Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg or (Inj, vancomycin hcl (xellia)) for short. HCPCS J3372 has been effective since 07/01/2025 and applies to Medical care.

HCPCS Code Details - J3372

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J3372
Description

Long description:
Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg

Short description:
Inj, vancomycin hcl (xellia)

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code D - Special coverage instructions apply
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2025
Date added Added Jan 01, 2023
Termination date Jun 30, 2025

See also

  • HCPCS J3370 · Injection, vancomycin hcl, 500 mg

  • HCPCS J3371 · Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg

  • HCPCS J3376 · Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg

  • HCPCS J3373 · Injection, vancomycin hydrochloride, 10 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/24/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.